Searching for NF-kappaB-based treatments of ischemia reperfusion injury (Q37618218)

21 August 2017

1 reference

title

Searching for NF-kappaB-based treatments of ischemia reperfusion injury (English)

1 reference

21 August 2017

0 references

1 reference

Christopher A Latanich

series ordinal

1

1 reference

PubMed ID

19842907

21 August 2017

Luis H Toledo-Pereyra

series ordinal

2

1 reference

21 August 2017

1 July 2009

1 reference

Journal of Investigative Surgery

21 August 2017

1 reference

21 August 2017

22

1 reference

21 August 2017

4

1 reference

21 August 2017

301-315

1 reference

Control of B lymphocyte apoptosis by the transcription factor NF-kappaB.

21 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB regulation in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Hypoxia up-regulates hypoxia-inducible factor-1alpha transcription by involving phosphatidylinositol 3-kinase and nuclear factor kappaB in pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Regulation of hypoxia-inducible factor-1alpha by NF-kappaB

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Possible new role for NF-kappaB in the resolution of inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Rel/NF-kappa B and I kappa B proteins: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

HMGB1 preconditioning: therapeutic application for a danger signal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB at the crossroads of life and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Exploiting endogenous anti-apoptotic proteins for novel therapeutic strategies in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB and the innate immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Is NF-kappaB2/p100 a direct activator of programmed cell death?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

p53 and NF-kappaB crosstalk: IKKalpha tips the balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

IkappaB kinase-independent IkappaBalpha degradation pathway: functional NF-kappaB activity and implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Duration of nuclear NF-kappaB action regulated by reversible acetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Deubiquitylation and regulation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Apoptosis and nuclear factor-kappa B: a tale of association and dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

IkappaBbeta, but not IkappaBalpha, functions as a classical cytoplasmic inhibitor of NF-kappaB dimers by masking both NF-kappaB nuclear localization sequences in resting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

IkappaB kinases: key regulators of the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Roles of nuclear factor-kappaB in postischemic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

NF-kappaB activation by reactive oxygen species: fifteen years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Pre-conditioning and postconditioning to limit ischemia-reperfusion-induced myocardial injury: what could be the next footstep?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Protein kinase Cdelta selectively regulates protein kinase D-dependent activation of NF-kappaB in oxidative stress signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Reduction of myocardial ischemia-reperfusion injury with pre- and postconditioning: molecular mechanisms and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Renal protection by delayed ischaemic preconditioning is associated with inhibition of the inflammatory response and NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Transient limb ischemia induces remote ischemic preconditioning in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Surgical implications of ischemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Remote ischaemic preconditioning: underlying mechanisms and clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Ischemic preconditioning in solid organ transplantation: from experimental to clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Cardiac role of the transcription factor NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

TNFalpha in ischemia/reperfusion injury and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Tumor necrosis factor alpha, rapid ventricular tachyarrhythmias, and infarct size in canine models of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Inhibition of tumor necrosis factor-alpha -induced nuclear translocation and activation of NF-kappa B by dehydroxymethylepoxyquinomicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Nuclear factor-kappaB decoy oligodeoxynucleotides attenuates ischemia/reperfusion injury in rat liver graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Improvement of recipient survival after small size graft liver transplantation in rats with preischemic manipulation or administering antisense against nuclear factor-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Role of NF-κB in p53-mediated programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

Ischemic Pre-conditioning in Deceased Donor Liver Transplantation: A Prospective Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08941930903040155

10.1080/08941930903040155

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19842907